Publication:
The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain

Loading...
Thumbnail Image
Date
2020-01-01T00:00:00Z
Authors
Erken, Neziha
Gunay, Fatma Sena Dost
SOYSAL, PINAR
IŞIK, AHMET TURAN
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue

Metrics

Search on Google Scholar

Abstract
Chemobrain is one of the problems that may arise during or after treatment and there is currently no specific treatment for this condition. Our case was a 76-year-old female patient who presented to our clinic with complaints of forgetfulness that did not affect daily living activities for the last year. Breast cancer was diagnosed in 2013 and she has been receiving anastrozole treatment for 6 years after local mass excision surgery and radiotherapy. After a comprehensive geriatric evaluation, cognitive impairment due to systemic cancer therapy was detected and treatment was started with Theracurmin 90 mg twice a day therapy. After 3-months of Theracurmin therapy, she had no cognitive improvement during the follow-up. This case report demonstrated that Theracurmin treatment may be a new option for chemobrain.
Description
Keywords
Cancer, Theracurmin, Chemobrain, Cognitive impairment, Elderly
Citation
Erken N., Gunay F. S. D. , SOYSAL P., IŞIK A. T. , -The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain-, CLINICAL INTERVENTIONS IN AGING, cilt.15, ss.691-693, 2020
Page Views

0

File Downloads

3

Sustainable Development Goals